By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


RCN welcomes pledge on overuse of antipsychotics in dementia

The Department of Health’s pledge to tackle the overuse of antipsychotic drugs for treating dementia has been welcomed by the RCN

A new national clinical director for dementia and better regulation are among the plans proposed by the Department of Health to stop anti-psychotic drugs being prescribed to people with dementia.

RCN chief executive and general secretary Dr Peter Carter said: “We look forward to working with the new national clinical director for dementia on these ambitious proposals which offer hope for patients with dementia and their families.

“Dementia, in the absence of a cure, will affect increasing numbers of people in the coming years. To ensure these patients receive the best possible care, it is vital that all health and social care staff working with dementia patients receive appropriate specialist training.”

An independent review commissioned by the Department of Health found that too many people with dementia are routinely prescribed anti-psychotic drugs to treat agitation and aggression.

Have your say

You must sign in to make a comment.